Mave Health is listing the headset at $495 for pre-orders. It aims to ship devices to users in the U.S. and India in April ...

Add Yahoo as a preferred source to see more of our stories on Google. Neuromodulation systems are becoming increasingly popular for the treatment of UUI. Credit: designerNFMR / Shutterstock.com.

ReShape Lifesciences has received a Notice of Allowance from the U.S. Patent and Trademark Office for its patent application on a new Diabetes Neuromodulation system utilizing its vagal nerve block ...

New data show that wearable neuromodulation can be used with CGMs without disrupting glucose accuracy or connectivity.

Given the growing interest in non-invasive neuromodulation devices for the central nervous system, the Forum on Neuroscience and Nervous System Disorders hosted a public workshop on March 2-3, 2015 to ...

Boston Scientific added SNM to its urology portfolio following its 2024 acquisition of Axonics.

PLANO, Texas, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), one of the largest medical device contract development and manufacturing organizations (CDMO) in the world, ...

ReShape Lifesciences® announced the presentation of pre-clinical data for its innovative Diabetes Neuromodulation device at the Minnesota Neuromodulation Symposium. This device employs Hypoglycemia ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Neuromodulation offers personalized, responsive ...

The demand for advanced Neurodegenerative Disease Devices is being significantly driven by the growing burden of progressive neurological disorders ...